Your search returned 7 results.

Results
	1.	Impairment and employment issues after nerve repair in the hand and forearm. [electronic resource] by Meiners, P M Coert, J H Robinson, P H Meek, M F Producer: 20051101 In: Disability and rehabilitation vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab. [electronic resource] by Meiners, P M Arends, S Brouwer, E Spijkervet, F K L Vissink, A Bootsma, H Producer: 20120925 In: Annals of the rheumatic diseases vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial. [electronic resource] by Moerman, R V Arends, S Meiners, P M Brouwer, E Spijkervet, F K L Kroese, F G M Vissink, A Bootsma, H Producer: 20140219 In: Annals of the rheumatic diseases vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. [electronic resource] by Meijer, J M Meiners, P M Vissink, A Spijkervet, F K L Abdulahad, W Kamminga, N Brouwer, E Kallenberg, C G M Bootsma, H Producer: 20100504 In: Arthritis and rheumatism vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study. [electronic resource] by Abdulahad, W H Meijer, J M Kroese, F G M Meiners, P M Vissink, A Spijkervet, F K L Kallenberg, C G M Bootsma, H Producer: 20110523 In: Arthritis and rheumatism vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome. [electronic resource] by Pollard, R P E Abdulahad, W H Bootsma, H Meiners, P M Spijkervet, F K L Huitema, M G Burgerhof, J G M Vissink, A Kroese, F G M Producer: 20140120 In: Annals of the rheumatic diseases vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). [electronic resource] by Meiners, P M Vissink, A Kroese, F G M Spijkervet, F K L Smitt-Kamminga, N Sillevis Abdulahad, W H Bulthuis-Kuiper, J Brouwer, E Arends, S Bootsma, H Producer: 20140818 In: Annals of the rheumatic diseases vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)